Invited speakers and chairpersons from abroad for the Summer Symposium

1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th 11th 12th 13th 14th 15th 16th 17th 18th 19th 20th 21st 22nd 23rd 24th 25th

The 25th Seminar, 2005

Toward Personalized Medicine in Cancer and other Life-style Related Disease

R G H Cotton ( Carlton South, Australia )

M J Ratain ( Chicago, U.S.A. )

D R Cox ( Mountain View, U.S.A. )

W A Border ( Salt Lake City, U.S.A. )

L Wasserman ( La Jolla, U.S.A. )

J S Ross ( Albany, U.S.A. )

D L DeMeo ( Boston, U.S.A. )

L J Baier ( Phoenix, U.S.A. )

M R Thursz ( London, U.K.)

H Hakonarson ( Reykjavik, Iceland)

M Carrington ( Frederick, U.S.A. )

▲ Page Top　

The 24th Seminar, 2004

Pharmacogenomics in Cancer Chemotherapy:

Recent Advances in ABC Transporters and Genome Analyses

V Ling ( Vancouver, Canada )

A T Fojo ( Bethesda, U.S.A. )

R Safaei ( La Jolla, U.S.A. )

M M Gottesman ( Bethesda, U.S.A. )

B Sarkadi ( Budapest, Hungary )

P Borst ( Amsterdam, the Netherlands )

P K J Kinnunen ( Helsinki, Finland )

R Kerb ( Mölndal, Sweden )

M Jonge ( Rotterdam, the Netherlands )

▲ Page Top　

The 23rd Seminar, 2003

Immunology-based Targeting Therapy

D P Carbone ( Tennessee, U.S.A. )

R Wang ( Texas, U.S.A. )

M Smyth ( Victoria, Australia )

D E Speiser ( Lausanne, Switzerland )

R A Reisfeld ( California, U.S.A. )

S Ferrone ( New York, U.S.A. )

Y-T Chen ( New York, U.S.A. )

▲ Page Top　

The 22nd Seminar, 2002

Cancer Epigenetics

J-P J Issa ( Houston, U.S.A. )

Y Nakatani ( Boston, U.S.A. )

J F Costello ( San Francisco, U.S.A. )

S Toyooka ( Dallas, U.S.A. )

▲ Page Top　

The 21st Seminar, 2001

Epstein-Barr Virus and Human Cancer

R Ambinder

( Baltimore, U.S.A. )

G Bornkamm

( Munich, Germany )

J-Y Chen

( Taipei, Taiwan )

MA Epstein

( Oxford, U.K. )

I Ernberg

( Stockholm, Sweden )

P Farrell

( London, U.K. )

W Hammerschmidt

( Munich, Germany )

DP Huang

( Hong Kong, China )

L Hutt-Fletcher

( Kansas City, U.S.A. )

I Joab

( Paris, France )

E Kieff

( Boston, U.S.A. )

R Longnecker

( Chicago, U.S.A. )

G Miller

( New Haven, U.S.A. )

D Moss

( Brisbane, Australia )

T Ooka

( Lyon, France )

N Raab-Traub

( Chapel Hill, U. S. A. )

CM Rooney

( Houston, U.S.A. )

J Sample

( Memphis, U.S.A. )

T Scullcy

( Brisbane, Australia )

B Sugden

( Madison, U.S.A. )

F Wang

( Boston, U.S.A. )

C-S Yang

( Taipei, Taiwan )

LS Young

( Birmingham, U.K. )

▲ Page Top　

The 20th Seminar, 2000

Gene-Environment Interaction and Cancer Prevention

M A Y Ariyaratne

( Nugegoda, Sri Lanka )

H Bartsch

( Heidelberg, Germany )

S J Chen

( Beijing, P. R. of China )

R H Dashwood

( Corvallis, U.S.A. )

R C Garner

( England, U.K. )

M J Hill

( Berks, U.K. )

F F Kadlubar

( Jefferson, U.S.A. )

T Kensler

( Baltimore, U.S.A. )

B H Lee

( Jeonbuk, Korea )

I P Lee

( Seoul, Korea )

S J Lee

( Jeonbuk, Korea )

E Mihich

( NY, U.S.A. )

R Montesano

( Cedex, France )

S Narod

( Ontario, Canada )

S H Oh

( Jeonbuk, Korea )

Y J Surh

( Seoul, Korea )

V Turusov

( Moscow, Russia )

H Wenhsien

( Chiayi, Taiwan )

P Yang

( Minnesota, U.S.A. )

K S Zaenker

( Witten, Germany )

M Zhang

( Wanchai, Hong Kong )

Y H Zhang

( Beijing, P.R.of China )

▲ Page Top　

The 19th Seminar, 1999

Cancer Genomics and Molecular Diagnosis

L A Aaltonen

( Helsinki, Finland )

D Bowtell

( Melbourne, Australia )

C Caldas

( Cambridge, U.K. )

J W Gray

( San Francisco, U.S. A.)

O Kallioniemi

( Bethesda, U.S.A. )

M Perucho

( La Jolla, U.S.A. )

B Ponder

( Cambridge, U.K. )

G J Riggins

( Durham, U.K. )

Y Shloh

( Ramat Aviv, Israel )

M, H Skolnick

( Salt Lake City, U.S.A. )

▲ Page Top　

The 18th Seminar, 1998

Regulation of Machinery for Cancer Cell

Growth, Immortality, Apoptosis and Invasion

J Yuan

( Boston, U.S.A. )

R V Talanian

( Worcester, U.S.A. )

R Derynck

( San Francisco, U.S.A. )

X -F Wang

( Durham, U.S.A. )

A Balmain

( Richmond, U.S.A. )

R Khokha

( Toronto, Canada )

P D Brown

( Oxford, U.K. )

K H Plate

( Freiburg, Germany )

S E Holt

( Dallas, U.S.A. )

M Meyerson

( Boston, U.S.A. )

▲ Page Top　

The 17th Seminar, 1997

Cytoskeleton and G proteins in the Regulation of Cancer

M Baehler

( Munich, Germany )

A B Ze'ev

( Rehovot, Israel )

A W Burgess

( Melbourne, Australia )

C Y Chou

( Tainan, Taiwan )

J Downward

( London, U.K. )

E R Fearon

( Ann Arbor, U.S.A. )

H R Gautam

( Kathmandu, Nepal )

J B Gibbs

( West Point, U.S.A. )

A Hall

( London, U.K. )

K F Hsu

( Tainan, Taiwan )

B D Hwang

( Daejeon, Korea )

J H Kim

( Chuncheon, Korea )

C C Kumar

( Kenilworth, U.S.A. )

H Maruta

( Melbourne, Australia )

E Mihich

( Buffalo, U.S.A. )

A C Murphy

( Melbourne, Australia )

M S Parya

( Tabriz, Iran )

P Polakis

( Richmond, U.S.A. )

C Rai

( Kathmandu, Nepal )

T P Stossel

( Boston, U.S.A. )

▲ Page Top　

The 16th Seminar, 1996

Molecular Mechanisms for Inflammation-promoted Pathogenesis of Cancer

W A Anwar

( Cairo, Egypt. )

C W Boone

( Bethesda, U.S.A. )

S Christen

( Berkeley, U.S.A. )

J Gu

( Nanjing, China )

M R Hao

( Nanjing, China )

G Hong

( Nanjing, China )

Z L Hu

( Nanjing, China )

R S Kerbel

( Toronto, Canada )

L A Lampson

( Boston, U.S.A. )

I P Lee

( Laurel, U.S.A. )

H Mukhtar

( Cleveland, U.S.A. )

T M Oberyszyn

( Columbus, U.S.A. )

H Ohshima

( Lyon, France )

R Oyasu

( Chicago, U.S.A. )

J Parsonnet

( Stanford, U.S.A. )

S Satarug

( Tucson, U.S.A. )

M K Shigenaga

( Berkeley, U.S.A. )

Y Zhu

( Nanjing, China )

▲ Page Top　

The 15th Seminar, 1995

Psycho-Neuro-immunology and Cancer

H O Besedovsky

( Marburg, Germany )

E Alleva

( Rome, Italy )

R Glaser

( Columbus, U.S.A. )

N R S Hall

( Florida, U.S.A. )

R B Herberman

( Pittsburgh, U.S.A. )

A d Rey

( Marburg, Germany )

Y Shavit

( Jerusalem, Israel )

K Masek

( Prague, Czechoslovakia )

L R Temoshok

( Geneva, Switzerland )

D H Bovbjerg

( New York, U.S.A. )

K S Zänker

( Witten, Germany )

▲ Page Top　

The 14th Seminar, 1994

Genetic Polymorphism and Cancer Susceptibility

F J Gonzalez

( Bethesda, U.S.A. )

P F Guengerich

( Nashville, U.S.A. )

F F Kadlubar

( Jefferson, U.S.A. )

H Bartsch

( Heidelberg, Germany )

R A Branch

( Pittsburgh, U.S.A. )

N E Caporaso

( Bethesda, U.S.A. )

J Doehmer

( Munich, Germany )

J D Groopman

( Baltimore, U.S.A. )

F Oesch

( Mainz, Germany )

P Yongvanit

( Khon-Kaen, Thailand )

▲ Page Top　

The 13th Seminar, 1993

Current Strategies of Cancer Chemoprevention

D A Balentine

( Englewood Cliffs, U.S.A. )

C W Boone

( Bethesda, U.S.A. )

A Costa

( Milano, Italy )

D Earnest

( Tucson, U.S.A. )

P Greenwald

( Bethesda, U.S.A. )

M N Gould

( Madison, U.S.A. )

W K Hong

( Houston, U.S.A. )

S Y Kim

( Daejeon, Korea )

M. Lipkin

( New York, U.S.A. )

H F Pierson

( Woodinville, U.S.A. )

M J Wargovich

( Houston, U.S.A. )

L W Wattenberg

( Minneapolis, U.S.A. )

▲ Page Top　

The 12th Seminar, 1992

Oxyradicals and Antioxidative Responses in Cancer

C B Pickett

( Quebec, Canada )

O W Griffith

( Milwaukee, U.S.A. )

P A Baeuerle

( Munich, Germany )

H F Deutsch

( Madison, U.S.A. )

R A Floyd

( Oklahoma City, U.S.A. )

B Halliwell

( Sacramento, U.S.A. )

J B Hibbs Jr.

( Salt Lake City, U.S.A. )

L A Loeb

( Seattle, U.S.A. )

A Meister

( New York, U.S.A. )

M K Shigenaga

( Berkeley, U.S.A. )

G Storz

( Bethesda, U.S.A. )

H Ashraf

( Alexandria, Egypt. )

▲ Page Top　

The 11th Seminar, 1991

Molecules in Carcinogenic Processes

A Balmain

( Glasgow, U.K. )

D A Haber

( Massachusetts, U.S.A. )

E Harlow

( Massachusetts, U.S.A. )

R Horritz

( Massachusetts, U.S.A. )

B Ludeke

( Boston, U.S.A. )

F McCormick

( California, U.S.A. )

H L Moses

( Nashville, U.S.A. )

K Munger

( Bethesda, U.S.A. )

M Oren

( Rehovot, Israel )

M Perucho

( California, U.S.A. )

J N Pines

( California, U.S.A. )

F J Rauscher Ⅲ

( Philadelphia, U.S.A. )

N K Tonks

( New York, U.S.A. )

P K Vogt

( Los Angeles, U.S.A. )

A Wittinghofer

( Heidelberg, Germany )

▲ Page Top　

The 10th Seminar, 1990

The 9th Seminar, 1989

Cell Differentiation and Cancer Control

H P Koeffler

( Los Angeles, U.S.A. )

L Degos

( Paris, France )

R Lotan

( Houston, U.S.A. )

A Block

( Buffalo, U.S.A. )

R E Gallagher

( New York, U.S.A. )

N A Nicola

( Melbourne, Australia )

I Olsson

( Lund, Sweden )

J D Griffin

( Boston, U.S.A. )

T R Breitman

( Bethesda, U.S.A. )

D Tarin

( Oxford, U.K. )

J C Salomon

( Paris, France )

G A Bannikov

( Moscow, U.S.S.R. )

Yu M Vasiliev

( Moscow, U.S.S.R. )

G B Pierce

( Denver, U.S.A. )

Y S Kim

( San Francisco, U.S.A. )

G Abelev

( Moscow, U.S.S.R. )

▲ Page Top　

The 8th Seminar, 1988

Cancer Progression & Metastasis

E Sugarbaker

( Miami, U.S.A. )

D Tarin

( Oxford, U.K. )

G L Nicolson

( Houston, U.S.A. )

A Raz

( Detroit, U.S.A. )

L Furcht

( Minneapolis, U.S.A. )

L Eisenbach

( Rehovot, Israel )

R Kerbel

( Toronto, Canada )

G Heppner

( Detroit, U.S.A. )

A Stavrovskaya

( Moscow, U.S.S.R. )

G Deichman

( Moscow, U.S.S.R. )

M Kripke

( Houston, U.S.A. )

R Greig

( Prussia, U.S.A. )

J Fidler

( Houston, U.S.A. )

K V Honn

( Detroit, U.S.A. )

P Frost

( Houston, U.S.A. )

V Schirrmacher

( Heidelberg, W. Germany )

E Mihich

( Buffalo, U.S.A. )

▲ Page Top　

The 7th Seminar, 1987

Primary & Secondary Prevention of Cancer

Alan S Morrison

( Providence, U.S.A. )

M Hakama

( Tampere, Finland )

F de Waard

( utrecht, the Netherlands )

R K Ross

( Los Angeles, U.S.A. )

John A H Lee

( Seattle, U.S.A. )

R S Fontana

( Rochester, U.S.A. )

C H Hennekens

( Boston, U.S.A. )

S H Lu

( Beijing, R.P. of China )

C W Boone

( Bethesda, U.S.A. )

▲ Page Top　

The 6th Seminar, 1986

Viruses, Immunodeficiency, and Human Cancer

D T Purtilo

( Omaha, U.S.A. )

Y Zeng

( Beijing, P.R. of China )

P Ebbesen

( Aarhus, Denmark )

D Volsky

( Omaha, U.S.A. )

G R Pearson

( Washington, D.C., U.S.A.)

T Mak

( Toronto, Canada )

M Nonoyama

( St. Petersburg, U.S.A. )

D W Hanto

( St Louis, U.S.A. )

D Abrams

( San Francisco, U.S.A. )

G Klein

( Stockholm, Sweden )

D T Purtilo

( Omaha, U.S.A. )

G R Pearson

( Washington, D.C., U.S.A. )

A Rubinstein

( New York, U.S.A. )

▲ Page Top　

The 5th Seminar, 1985

Monoclonal Antibodies :

Progress in Cancer Immunobiology and Clinical Application

R A Reisfeld

( La Jolla, U.S.A. )

B Fenderson

( Seattle, U.S.A. )

B M Longenecker

( Edmonton, Canada )

S Levy

( Stanford, U.S.A. )

J Ritz

( Boston, U.S.A. )

A P Jarvis

( Needham Height, U.S.A. )

S von Kleist

( Freiburg, W. Germany )

S Ferrone

( Valhalla, U.S.A. )

M I Greene

( Boston, U.S.A. )

R M Nakamura

( La Jolla, U.S.A. )

R Levy

( Stanford, U.S.A. )

D A Charesh

( La Jolla, U.S.A. )

A N Houghton

( New York, U.S.A. )

L L Houston

( Emeryville, U.S.A. )

▲ Page Top　

The 4th Seminar, 1984

Viral Transforming Genes and Oncogenes :

Origin, Structure, and Function

F Rapp

( Hershey, U.S.A. )

D T Purtilo

( Omaha, U.S.A. )

M Nonoyama

( St. Petersburg, U.S.A. )

Y Sawada

( Stony Brook, U.S.A. )

A J van der Eb

( Leiden, the Netherlands )

W Doerfie

( Cologne, W. Germany )

S Hashimoto

( St. Louis, U.S.A. )

Y Gluzman

( Cold Spring Harbor, U.S.A. )

R Henning

( Ulm, W. Germany )

T L Benjamin

( Boston, U.S.A. )

P K Vogt

( Los Angeles, U.S.A. )

W S Hayward

( New York, U.S.A. )

T S Papas

( Frederick, U.S.A. )

S Sukumar

( Frederick, U.S.A. )

▲ Page Top　

The 3rd Seminar, 1983

Biological Responses in Cancer Chemotherapy

A Fefer

( Seattle, U.S.A. )

H T Wepsic

( Chicago, U.S.A. )

J L Turk

( London, U.K. )

S Ozer

( Buffalo, U.S.A. )

A Mantovani

( Milan, Italy )

E Mihich

( Buffalo, U.S.A. )

S Dray

( Chicago, U.S.A. )

F Spreafico

( Milan, Italy )

▲ Page Top　

The 2nd Seminar, 1982

Membrane-Associated Alteration in Cancer :

Biochemical Strategies against Cancer

L Warren

( Philadelphia, U.S.A. )

E A Davidson

( Hershey, U.S.A. )

S Hakomori

( Seattle, U.S.A. )

A Novogrodsky

( Petah-Tikva, Israel )

G L Nicolson

( Houston, U.S.A. )

D F H Wallach

( Boston, U.S.A. )

P H Black

( Boston, U.S.A. )

H Schachter

( Toronto, Canada )

E G Berger

( Berne, Switzerland )

Y S Kim

( San Francisco, U.S.A. )

A Szewczuk

( Wroclow, Poland )

▲ Page Top　

The 1st Seminar, 1981

Escape of Tumor Cells from Immune Controls

I J Fidler

( Frederick, U.S.A. )

R W Baldwin

( Nottingham, U.K. )

H L Ioachim

( New York, U.S.A. )

J C Palmer

( Philadelphia, U.S.A. )

S H Ohanian

( Bethesda, U.S.A. )

E F Wheelock

( Philadelphia, U.S.A. )

M Vandeputte

( Leuven, Belgium )

M L Kripke

( Frederick, U.S.A. )

D Naor

( Jerusalem, Israel )

T Boon

( Brussels, Belgium )

E Mihich

( Buffalo, U.S.A. )

G Klein

( Stockholm, Sweden )

D J Cameron

( Charleston, U.S.A. )

▲ Page Top　

TopPage	Sapporo Cancer Seminar Foundation		Main Projects		Profile of Sapporo, Hokkaido
Summer Symposium		Invited speakers and chairpersons		Winter Symposium		Directers and Sponsors